Hepatic Involvement and Portal Hypertension Predict Mortality in Chronic Granulomatous Disease

Gastroenterology

Volumn 134, Issue 7, 2008, Pages 1917-1926

  Feld, Jordan J ^a   Hussain, Nadeem ^a   Wright, Elizabeth C ^a   Kleiner, David E ^b   Hoofnagle, Jay H ^a   Ahlawat, Sushil ^a   Anderson, Victoria ^c   Hilligoss, Dianne ^c   Gallin, John I ^c   Liang, T Jake ^a   Malech, Harry L ^c   Holland, Steven M ^c   Heller, Theo ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD VESSEL INJURY; CAUSE OF DEATH; CHILD; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INFECTIOUS COMPLICATION; LIVER ABSCESS; LIVER VEIN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MORTALITY; PORTAL HYPERTENSION; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK ASSESSMENT; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VEIN DIAMETER; VENOUS PRESSURE;

EID: 44649176500     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.02.081     Document Type: Article

References (41)

1. Jurkowska M., Bernatowska E., and Bal J. Genetic and biochemical background of chronic granulomatous disease. Arch Immunol Ther Exp (Warsz) 52 (2004) 113-120
2. Heyworth P.G., Cross A.R., and Curnutte J.T. Chronic granulomatous disease. Curr Opin Immunol 15 (2003) 578-584
3. Johnston Jr. R.B. Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 8 (2001) 17-22
4. Lublin M., Bartlett D.L., Danforth D.N., et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg 235 (2002) 383-391
5. Marciano B.E., Wesley R., De Carlo E.S., et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39 (2004) 692-699
6. Gallin J.I., Alling D.W., Malech H.L., et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348 (2003) 2416-2422
7. Hussain N., Feld J.J., Kleiner D.E., et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 45 (2007) 675-683
8. Caly W.R., and Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 18 (1993) 353-358
9. Thulstrup A.M., Sorensen H.T., Schonheyder H.C., et al. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 31 (2000) 1357-1361
10. Deschenes M., and Villeneuve J.P. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol 94 (1999) 2193-2197
11. Bernard B., Cadranel J.F., Valla D., et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 108 (1995) 1828-1834
12. Follo A., Llovet J.M., Navasa M., et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20 (1994) 1495-1501
13. Lin R.S., Lee F.Y., Lee S.D., et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22 (1995) 165-172
14. Vowells S.J., Sekhsaria S., Malech H.L., et al. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 178 (1995) 89-97
15. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324 (1991) 509-516
16. Margolis D.M., Melnick D.A., Alling D.W., et al. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 162 (1990) 723-726
17. Groszmann R.J., and Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39 (2004) 280-282
18. Grambsch P., and Therneau T.M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
19. Cleves M.A. Multiple curves plotted with stcurve command. Stata Technical Bull 54 (2000) 2-4
20. Schepis F., Camma C., Niceforo D., et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?. Hepatology 33 (2001) 333-338
21. Reshamwala P.A., Kleiner D.E., and Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 44 (2006) 7-14
22. Kondo F., Koshima Y., and Ebara M. Nodular lesions associated with abnormal liver circulation. Intervirology 47 (2004) 277-287
23. Shimamatsu K., and Wanless I.R. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 26 (1997) 343-350
24. Czaja A.J., Wolf A.M., and Baggenstoss A.H. Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findings. Mayo Clin Proc 55 (1980) 360-364
25. Watt K., Uhanova J., Gong Y., et al. Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat 11 (2004) 251-256
26. Tarantino M. Recent advances in the treatment of childhood immune thrombocytopenic purpura. Semin Hematol 43 (2006) S11-S19
27. Prytz H., Bjorneboe M., Christoffersen P., et al. Correlation between hepatic morphology and immunoglobulins and antibodies to Escherichia coli in cirrhosis. Gut 18 (1977) 28-32
28. Aster R.H. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 45 (1966) 645-657
29. Naber A.H., Van Haelst U., and Yap S.H. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 12 (1991) 94-99
30. O'Brien K., Hussain N., Warady B.A., et al. Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol 4 (2006) 387-394
31. Colina F., Pinedo F., Solis J.A., et al. Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology 102 (1992) 1319-1324
32. Ueno S., Tanabe G., Sueyoshi K., et al. Hepatic hemodynamics in a patient with nodular regenerative hyperplasia. Am J Gastroenterol 91 (1996) 1012-1015
33. Dubinsky M.C., Vasiliauskas E.A., Singh H., et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 125 (2003) 298-303
34. Battista S., Bar F., Mengozzi G., et al. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 26 (1997) 75-80
35. Rasaratnam B., Kaye D., Jennings G., et al. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 139 (2003) 186-193
36. Rizvi M.R., Omanwar S., Fahim M., et al. Altered alpha adrenergic vasoresponsiveness in a non-cirrhotic portal hypertension model of E. coli injection. J Gastroenterol Hepatol 22 (2007) 870-876
37. Cirera I., Bauer T.M., Navasa M., et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 34 (2001) 32-37
38. Wiest R., and Rath H.C. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 17 (2003) 397-425
39. Davis I.D., Ho M., Hupertz V., et al. Survival of childhood polycystic kidney disease following renal transplantation: the impact of advanced hepatobiliary disease. Pediatr Transplant 7 (2003) 364-369
40. Ferraz A.A., Campos J.M., Junior J.G., et al. Gut bacterial translocation and postoperative infections: a prospective study in schistosomotic patients. Surg Infect (Larchmt) 6 (2005) 197-201
41. Kashtan C.E., Primack W.A., Kainer G., et al. Recurrent bacteremia with enteric pathogens in recessive polycystic kidney disease. Pediatr Nephrol 13 (1999) 678-682